Gene · 5754
Papers1,606
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,606
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients. | Genes Dis | 2023 | 37397537 | PubTator, text mining | PubMed |
| Arising Novel Agents in Lung Cancer: Are Bispecifics and ADCs the New Paradigm? | Cancers (Basel) | 2023 | 37370772 | PubTator, text mining | PubMed |
| PTK7 is a positive allosteric modulator of GPR133 signaling in glioblastoma. | Cell Rep | 2023 | 37354459 | PubTator, text mining | PubMed |
| Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies. | J Hematol Oncol | 2023 | 37353849 | PubTator, text mining | PubMed |
| MTX-13, a Novel PTK7-Directed Antibody-Drug Conjugate with Widened Therapeutic Index Shows Sustained Tumor Regressions for a Broader Spectrum of PTK7-Positive Tumors. | Mol Cancer Ther | 2023 | 37352387 | PubTator, text mining | PubMed |
| Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma. | Cell Rep Med | 2023 | 37343516 | PubTator, text mining | PubMed |
| Oncogene-targeting nanoprobes for early imaging detection of tumor. | J Nanobiotechnology | 2023 | 37340418 | PubTator, text mining | PubMed |
| N-terminal proteoforms may engage in different protein complexes. | Life Sci Alliance | 2023 | 37316325 | PubTator, text mining | PubMed |
| Immunotherapy through the Lens of Non-Small Cell Lung Cancer. | Cancers (Basel) | 2023 | 37296957 | PubTator, text mining | PubMed |
| A quest for genetic causes underlying signaling pathways associated with neural tube defects. | Front Pediatr | 2023 | 37284286 | PubTator, text mining | PubMed |
| Modernising autism spectrum disorder model engineering and treatment via CRISPR-Cas9: A gene reprogramming approach. | World J Clin Cases | 2023 | 37274051 | PubTator, text mining | PubMed |
| Single-cell sequencing technology in colorectal cancer: a new technology to disclose the tumor heterogeneity and target precise treatment. | Front Immunol | 2023 | 37256123 | PubTator, text mining | PubMed |
| Seeking a better understanding of the non-receptor tyrosine kinase, SRMS. | Heliyon | 2023 | 37251450 | PubTator, text mining | PubMed |
| Click chemistry and drug delivery: A bird's-eye view. | Acta Pharm Sin B | 2023 | 37250163 | PubTator, text mining | PubMed |
| Structural Optimization and Interaction Study of a DNA Aptamer to L1 Cell Adhesion Molecule. | Int J Mol Sci | 2023 | 37239955 | PubTator, text mining | PubMed |
| Cytoskeletal Keratins Are Overexpressed in a Zebrafish Model of Idiopathic Scoliosis. | Genes (Basel) | 2023 | 37239418 | PubTator, text mining | PubMed |
| The First-in-Human Whole-Body Dynamic Pharmacokinetics Study of Aptamer. | Research (Wash D C) | 2023 | 37223462 | PubTator, text mining | PubMed |
| MiR-503 pleiotropically regulates epithelial-mesenchymal transition and targets PTK7 to control lung cancer metastasis. | Cancer Med | 2023 | 37212485 | PubTator, text mining | PubMed |
| Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVID. | Arch Microbiol | 2023 | 37193831 | PubTator, text mining | PubMed |
| A New Wave of Targeting 'Undruggable' Wnt Signaling for Cancer Therapy: Challenges and Opportunities. | Cells | 2023 | 37190019 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5754/papers?page=11